Peritoneal cell culture: fibroblasts.

PubWeight™: 0.90‹?›

🔗 View Article (PMID 16722018)

Published in Perit Dial Int on May 25, 2006

Authors

Janusz Witowski1, Achim Jörres

Author Affiliations

1: Department of Pathophysiology, University Medical School, Poznań, Poland. jwitow@amp.edu.pl

Articles by these authors

Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int (2003) 3.54

The proto-oncogene c-Fos transcriptionally regulates VEGF production during peritoneal inflammation. Kidney Int (2013) 1.54

Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-beta1. Lab Invest (2007) 1.50

Mild therapeutic hypothermia alters neuron specific enolase as an outcome predictor after resuscitation: 97 prospective hypothermia patients compared to 133 historical non-hypothermia patients. Crit Care (2010) 1.25

Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin. Am J Pathol (2009) 1.08

The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): a prospective randomized controlled trial. Crit Care (2014) 1.06

Changes in serum creatinine in the first 24 hours after cardiac arrest indicate prognosis: an observational cohort study. Crit Care (2009) 1.00

Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium. Int J Cancer (2010) 1.00

Senescence induces a proangiogenic switch in human peritoneal mesothelial cells. Rejuvenation Res (2008) 0.99

Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol (1985) (2005) 0.99

Mild therapeutic hypothermia shortens intensive care unit stay of survivors after out-of-hospital cardiac arrest compared to historical controls. Crit Care (2008) 0.98

Therapy-refractory Panton Valentine Leukocidin-positive community-acquired methicillin-sensitive Staphylococcus aureus sepsis with progressive metastatic soft tissue infection: a case report. J Med Case Rep (2007) 0.94

Effects of peritoneal dialysis solutions on the peritoneal membrane: clinical consequences. Perit Dial Int (2005) 0.90

Glucose degradation products in peritoneal dialysis fluids: do they harm? Kidney Int Suppl (2003) 0.89

Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells. Free Radic Biol Med (2008) 0.89

Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med (2006) 0.87

Mild hypothermia treatment in patients resuscitated from non-shockable cardiac arrest. Emerg Med J (2011) 0.87

Human peritoneal fibroblasts are a potent source of neutrophil-targeting cytokines: a key role of IL-1beta stimulation. Lab Invest (2009) 0.87

Mesothelial toxicity of peritoneal dialysis fluids is related primarily to glucose degradation products, not to glucose per se. Perit Dial Int (2003) 0.86

Artificial extracorporeal liver support therapy in patients with severe liver failure. Expert Rev Gastroenterol Hepatol (2011) 0.85

Serial measurement of neuron specific enolase improves prognostication in cardiac arrest patients treated with hypothermia: a prospective study. Scand J Trauma Resusc Emerg Med (2012) 0.84

Peritoneal dialysis fluids can alter HSP expression in human peritoneal mesothelial cells. Nephrol Dial Transplant (2010) 0.83

Application of spin label electron paramagnetic resonance in the diagnosis and prognosis of cancer and sepsis. Clin Chem Lab Med (2008) 0.83

The role of EUTox in uremic toxin research. Semin Dial (2009) 0.82

Vulnerability to oxidative stress and different patterns of senescence in human peritoneal mesothelial cell strains. Am J Physiol Regul Integr Comp Physiol (2008) 0.82

Inhaled nitric oxide for ARDS due to sickle cell disease. Swiss Med Wkly (2004) 0.80

Prehospital cooling with hypothermia caps (PreCoCa): a feasibility study. Clin Res Cardiol (2008) 0.79

Biocompatibility of a bicarbonate-buffered amino-acid-based solution for peritoneal dialysis. Pediatr Nephrol (2008) 0.79

Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis. Perit Dial Int (2008) 0.78

Peritoneal dialysis with solutions low in glucose degradation products is associated with improved biocompatibility profile towards peritoneal mesothelial cells. Nephrol Dial Transplant (2004) 0.78

New insights into the management of hepato-renal syndrome. Liver Int (2011) 0.78

Does tirofiban prevent platelet loss in patients after cardiogenic shock during continuous renal replacement therapy? Crit Care (2008) 0.77

Fate of the glucose degradation products 3-deoxyglucosone and glyoxal during peritoneal dialysis. Mol Nutr Food Res (2005) 0.77

Acute kidney injury in sepsis: transient or intrinsic? Crit Care (2013) 0.77

Extracorporeal liver support therapy with Prometheus in patients with liver failure in the intensive care unit. Ther Apher Dial (2009) 0.76

Periostin: a matricellular protein involved in peritoneal injury during peritoneal dialysis. Perit Dial Int (2013) 0.76

Recovery of senescent endothelial cells from injury. J Gerontol A Biol Sci Med Sci (2012) 0.75

Organ crosstalk in critically ill patients: hemofiltration and immunomodulation in sepsis. Blood Purif (2009) 0.75

Transfuse or not transfuse in acute renal failure? This is the question. Intensive Care Med (2005) 0.75

Preventing peritoneal fibrosis--an ace up our sleeve? Perit Dial Int (2005) 0.75

Hemofiltration or hemodialysis for acute kidney injury? Crit Care (2012) 0.75

Isoflurane Sedation on the ICU in Cardiac Arrest Patients Treated With Targeted Temperature Management: An Observational Propensity-Matched Study. Crit Care Med (2016) 0.75

Conservative treatment of the uremic syndrome. Semin Dial (2009) 0.75

HSP induction in mesothelial cells by peritoneal dialysis fluid depends on biocompatibility test system. Int J Artif Organs (2011) 0.75

The role of the glyoxalase pathway in reducing mesothelial toxicity of glucose degradation products. Perit Dial Int (2006) 0.75